Source: EURLEX
Language: en
Format: md

Judgment of the General Court of (Sixth Chamber) of 23 March 2017 — Cryo-Save v EUIPO — MedSkin Solutions Dr. Suwelack (Cryo-Save)

(Case T‑239/15)

(EU trade mark — Revocation proceedings — EU word mark Cryo-Save — Article 51(1)(a) of Regulation (EC) No 207/2009 — Genuine use of the mark — Burden of proof — Declaration of revocation)

| 1. | EU trade mark—Appeals procedure—Action before the EU judicature—Jurisdiction of the General Court—Re-evaluation of the facts in the light of evidence produced for the first time before it—Precluded  (Rules of Procedure of the General Court, Art. 188; Council Regulation No 207/2009, Art. 65)  (see para. 17) |

| 2. | EU trade mark—Surrender, revocation and invalidity—Causes of revocation—No genuine use of a trade mark—Proof of use of the earlier mark—Genuine use—Concept—Criteria for assessment  (Council Regulation No 207/2009, Arts 15(1), and 51(1)(a))  (see paras 29-34) |

Re:

ACTION brought against the decision of the Fourth Board of Appeal of EUIPO of 3 March 2015 (Case R 2567/2013-4), concerning revocation proceedings between MedSkin Solutions Dr. Suwelack and Cryo-Save.

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Cryo-Save AG to pay the costs. |

[Top](#document1)